SCHEMBL2175593

SCHEMBL2175593

CNc1nccc(-c2cc(NC3CCN(C(=O)OC(C)(C)C)CC3)c3cc(OC)ccc3c2)n1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DYRK1A Q13627 3/20 0.52
ALDH1A1 P00352 3/20 0.50
NOS3 P29474 1/20 0.43
NOS1 P29475 1/20 0.43
NOS2 P35228 1/20 0.43
NSD2 O96028 2/20 0.42
EHMT2 Q96KQ7 2/20 0.42
HTT P42858 3/20 0.42
SYK P43405 1/20 0.42
PIK3CA P42336 1/20 0.41
STS P08842 1/20 0.41
KDM1A O60341 1/20 0.41
RCOR1 Q9UKL0 1/20 0.41
DYRK2 Q92630 1/20 0.41
DNMT3A Q9Y6K1 1/20 0.40
MEN1 O00255 2/20 0.40
KMT2A Q03164 2/20 0.40
KDM4E B2RXH2 1/20 0.40
HPGD P15428 1/20 0.40
TSHR P16473 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2178139 0.95 DYRK1A (0.48) DYRK1AALDH1A1NSD2EHMT2HTT
SCHEMBL2177054 0.91 DYRK1A (0.43) DYRK1AALDH1A1EHMT2PIK3CA
SCHEMBL2176173 0.89 DYRK1A (0.51) DYRK1AALDH1A1NOS3NOS1NOS2
SCHEMBL2177116 0.87 SLC2A1 (0.44) DYRK1AALDH1A1HTTDYRK2MAPT
SCHEMBL2176320 0.85 NOS3 (0.41) DYRK1ANOS3NOS1NOS2
SCHEMBL6126567 0.85 IKBKB (0.48) EHMT2
SCHEMBL2175527 0.84 NOS2 (0.44) DYRK1AALDH1A1NOS3NOS1NOS2
SCHEMBL2179297 0.82 EIF2AK2 (0.41) PIK3CADNMT3AMEN1KMT2AKDM4E
SCHEMBL2175893 0.80 MKNK1 (0.51) DYRK1AALDH1A1PIK3CAKDM4ETSHR
SCHEMBL2178751 0.80 AAK1 (0.42) DYRK1APIK3CA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8173808-B2 Substituted naphthalenyl-pyrimidine compounds ARQULE, INC. (US) 2012-05-08 US claimed
EP-2519519-A2 SUBSTITUTED NAPHTHALENYL-PYRIMIDINE COMPOUNDS ArQule, Inc. (US) 2012-11-07 EP disclosed
US-8173808-B2 Substituted naphthalenyl-pyrimidine compounds ARQULE, INC. (US) 2012-05-08 US disclosed
US-8173808-B2 Substituted naphthalenyl-pyrimidine compounds ARQULE, INC. (US) 2012-05-08 US disclosed
US-8173808-B2 Substituted naphthalenyl-pyrimidine compounds ARQULE, INC. (US) 2012-05-08 US disclosed
US-20110166137-A1 Substituted Naphthalenyl-Pyrimidine Compounds ARQULE, INC. (US) 2011-07-07 US disclosed
WO-2011082268-A2 SUBSTITUTED NAPHTHALENYL-PYRIMIDINE COMPOUNDS ARQULE INC. (US) 2011-07-07 WO disclosed
US-20110166137-A1 Substituted Naphthalenyl-Pyrimidine Compounds ARQULE, INC. (US) 2011-07-07 US disclosed
US-20110166137-A1 Substituted Naphthalenyl-Pyrimidine Compounds ARQULE, INC. (US) 2011-07-07 US disclosed
WO-2011082268-A2 SUBSTITUTED NAPHTHALENYL-PYRIMIDINE COMPOUNDS ARQULE INC. (US) 2011-07-07 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110166137-A1 Substituted Naphthalenyl-Pyrimidine Compounds DPYD, TP53, TYMP DYRK1A 2574/4885ALDH1A1 619/4885NOS3 3297/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.